3 Recruiting Primary Myelofibrosis Phase 1 Clinical Trials
Active phase 1 studies for primary myelofibrosis enrolling across the USA. Verify eligibility and contact site coordinators.
All Primary Myelofibrosis studiesPhase 1 Studies for Primary Myelofibrosis
🟢 Recruiting Phase1 / Phase2
Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase1
Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition
📍 Fox Chase Cancer Center - Philadelphia — Philadelphia, Pennsylvania
View Study & Checklist ➔ 🟢 Recruiting Phase1
A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
📍 Stanford Cancer Institute — Palo Alto, California
View Study & Checklist ➔